These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 21454795)
1. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Priori SG; Chen SR Circ Res; 2011 Apr; 108(7):871-83. PubMed ID: 21454795 [TBL] [Abstract][Full Text] [Related]
2. Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin. Liu N; Priori SG Cardiovasc Res; 2008 Jan; 77(2):293-301. PubMed ID: 18006488 [TBL] [Abstract][Full Text] [Related]
14. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875 [TBL] [Abstract][Full Text] [Related]
15. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy. Watanabe H; Knollmann BC J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879 [TBL] [Abstract][Full Text] [Related]
16. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920 [TBL] [Abstract][Full Text] [Related]
17. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279 [TBL] [Abstract][Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Katz G; Arad M; Eldar M Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246 [TBL] [Abstract][Full Text] [Related]
19. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848 [TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function. Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]